BRISTOL-MYERS SQUIBB COMPANY Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $49.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-13.
Discontinued › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2015-02-13
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2014-12-31 was $14.00M.
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2014-09-30 was $4.00M, a 66.67% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2014-06-30 was $8.00M, a 75.76% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2014-03-31 was $23.00M, a 2200.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2014 was $49.00M.
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2013 was -$29.00M, a 103.92% decline from fiscal 2012.
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2012 was $740.00M, a 68.56% decline from fiscal 2011.
- BRISTOL-MYERS SQUIBB COMPANY noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2011 was $2.35B, a 11.67% increase from fiscal 2010.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month |
|---|---|---|---|---|
| 2014-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $18.00M derived: sum of 2 quarters · filed 2015-02-13 | $26.00M derived: sum of 3 quarters · filed 2015-02-13 | $49.00M 10-K · filed 2015-02-13 |
| 2014-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $12.00M derived: sum of 2 quarters · filed 2014-10-24 | $35.00M 10-Q · filed 2014-10-24 | -$40.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2014-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $31.00M 10-Q · filed 2014-07-24 | -$44.00M derived: sum of 3 quarters · filed 2015-02-13 | -$32.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2014-03-31 | $23.00M 10-Q · filed 2014-04-29 | -$52.00M derived: sum of 2 quarters · filed 2015-02-13 | -$40.00M derived: sum of 3 quarters · filed 2015-02-13 | -$7.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-12-31 | -$75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$63.00M derived: sum of 2 quarters · filed 2015-02-13 | -$30.00M derived: sum of 3 quarters · filed 2015-02-13 | -$29.00M 10-K · filed 2015-02-13 |
| 2013-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $45.00M derived: sum of 2 quarters · filed 2014-10-24 | $46.00M 10-Q · filed 2014-10-24 | $21.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $34.00M 10-Q · filed 2014-07-24 | $9.00M derived: sum of 3 quarters · filed 2015-02-13 | -$282.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $1.00M 10-Q · filed 2014-04-29 | -$24.00M derived: sum of 2 quarters · filed 2015-02-13 | -$315.00M derived: sum of 3 quarters · filed 2015-02-13 | $132.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$316.00M derived: sum of 2 quarters · filed 2015-02-13 | $131.00M derived: sum of 3 quarters · filed 2015-02-13 | $740.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | -$291.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $156.00M derived: sum of 2 quarters · filed 2013-10-23 | $765.00M 10-Q · filed 2013-10-23 | $1.28B derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $447.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $1.06B 10-Q · filed 2013-07-25 | $1.57B derived: sum of 3 quarters · filed 2014-02-14 | $2.09B derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $609.00M 10-Q · filed 2013-04-25 | $1.12B derived: sum of 2 quarters · filed 2014-02-14 | $1.64B derived: sum of 3 quarters · filed 2014-02-14 | $2.36B derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $512.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $1.03B derived: sum of 2 quarters · filed 2014-02-14 | $1.75B derived: sum of 3 quarters · filed 2014-02-14 | $2.35B 10-K · filed 2014-02-14 |
| 2011-09-30 | $523.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $1.24B derived: sum of 2 quarters · filed 2012-10-24 | $1.84B 10-Q · filed 2012-10-24 | $2.34B derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $720.00M 10-Q · filed 2011-07-28 | $1.32B 10-Q · filed 2012-07-25 | $1.81B derived: sum of 3 quarters · filed 2013-02-15 | $2.36B derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $599.00M 10-Q · filed 2012-04-26 | $1.09B derived: sum of 2 quarters · filed 2013-02-15 | $1.64B derived: sum of 3 quarters · filed 2013-02-15 | $2.22B derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $495.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $1.04B derived: sum of 2 quarters · filed 2013-02-15 | $1.62B derived: sum of 3 quarters · filed 2013-02-15 | $2.11B 10-K · filed 2013-02-15 |
| 2010-09-30 | $544.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $1.13B derived: sum of 2 quarters · filed 2011-10-27 | $1.61B 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $583.00M 10-Q · filed 2011-07-28 | $1.07B 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $486.00M 10-Q · filed 2011-04-28 | |||
| 2009-12-31 | $1.79B 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |